PeriRx’s breach of licensing contract suit can’t prevail

Oral diagnostics company PeriRx has lost a patent licensing suit against the University of California and research company RNAmeTRIX, claiming that they had breached sublicensing agreements.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

PeriRx sanctioned over false negotiation claims in patent suit

24 January 2022 PeriRx has been hit with sanctions over its conduct after its breach of licensing suit failed in a patent licensing dispute against the University of California.

Biotechnology

Bio-Rad and 10X Genomics end patent fight with new licensing deal

29 July 2021 Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products.

Europe

Bayer and ERS enter CRISPR patent licensing agreement

19 May 2016 Bayer and ERS Genomics have signed a patent licensing agreement which gives Bayer access to ERS’s CRISPR/Cas9 genome-editing patents.